From July 1, 2022 to December 31, 2022, the company has repurchased 2,335,000 shares, representing 0.41% for HKD 8 million. With this, the company has completed the repurchase of 3,132,000 shares, representing 0.55% for HKD 10.9 million under the buyback announced on May 12, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.6 HKD | +3.59% | +4.84% | +4.42% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.42% | 182M | |
+0.10% | 91.42B | |
+3.16% | 41.08B | |
-11.10% | 34.26B | |
+53.99% | 25.27B | |
-9.41% | 12.81B | |
-12.25% | 11.6B | |
-44.00% | 11.42B | |
+5.77% | 9.16B | |
-6.90% | 8.22B |
- Stock Market
- Equities
- 1061 Stock
- News Essex Bio-Technology Limited
- Tranche Update on Essex Bio-Technology Limited's Equity Buyback Plan announced on May 12, 2022.